NASDAQ:ROSG
Delisted

Rosetta Genomics Ltd. Fund Forecast

$0.430
+0 (+0%)
At Close: Jun 05, 2018
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

Red day on Tuesday for Rosetta Genomics Ltd. fund after losing 0%
(Updated on Jun 05, 2018)

Buy or Hold candidate since May 16, 2018 PDF

No changes to the price of Rosetta Genomics Ltd. fund on the last trading day (Tuesday, 5th Jun 2018). During the last trading day the fund fluctuated 0% from a day low at $0.430 to a day high of $0.430. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The fund lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the fund is expected to rise 6.00% during the next 3 months and, with a 90% probability hold a price between $0.368 and $0.491 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ROSG Signals & Forecast

The Rosetta Genomics Ltd. fund holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.430 and $0.415. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, May 18, 2018, and so far it has fallen -0.0233%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Rosetta Genomics Ltd. fund

Rosetta Genomics Ltd. finds support from accumulated volume at $0.420 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the fund tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the fund During the last day, the fund moved $0 between high and low, or 0%. For the last week the fund has had daily average volatility of 0%

The Rosetta Genomics Ltd. fund is extremely overbought on RSI14 (89). This increases the short-term risk substantially.

Our recommended stop-loss: $0.416 (-3.22%) (This fund has low daily movements and this gives low risk. The RSI14 is 89 and this increases the risk substantially. There is a sell signal from a pivot top found 11 days ago.)

Trading Expectations (ROSG) For The Upcoming Trading Day Of Wednesday 6th

For the upcoming trading day on Wednesday, 6th we expect Rosetta Genomics Ltd. to open at $0.430, and during the day (based on 14 day Average True Range), to move between $0.419 and $0.441, which gives a possible trading interval of +/-$0.0108 (+/-2.51%) up or down from last closing price. If Rosetta Genomics Ltd. takes out the full calculated possible swing range there will be an estimated 5.01% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.432 (0.49%) than the support at $0.420 (2.21%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Rosetta Genomics Ltd. fund A Buy?

Rosetta Genomics Ltd. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.420 Hold/Accumulate Unchanged

Predicted Opening Price for Rosetta Genomics Ltd. of Wednesday, June 6, 2018

Fair opening price June 6, 2018 Current price
$0.430 ( 0%) $0.430

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ROSG

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.430 .
R2 0.430 .
R1 0.430 .
Current price: 0.430
Support S1 0.430 .
S2 0.430 .
S3 0.430 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.440 2.35 %
R2 0.435 1.07 %
R1 0.432 0.488 %
Current price 0.430
Support S1 0.420 -2.21%
S2 0.410 -4.63%
S3 0.370 -13.93%

FAQ

What is the symbol for Rosetta Genomics Ltd. Fund and on which exchange is it traded?
The symbol for Rosetta Genomics Ltd. is ROSG and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Rosetta Genomics Ltd. Fund?
Rosetta Genomics Ltd. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Rosetta Genomics Ltd. Fund?
Rosetta Genomics Ltd. Fund can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Rosetta Genomics Ltd. Fund.

What's the current price of Rosetta Genomics Ltd. Fund?
As of the end of day on the Jun 05, 2018, the price of an Rosetta Genomics Ltd. (ROSG) share was $0.430.

What is the 52-week high and low for Rosetta Genomics Ltd. Fund?
The 52-week high for Rosetta Genomics Ltd. Fund is $2.75 and the 52-week low is $0.230.
Click to get the best stock tips daily for free!

About Rosetta Genomics Ltd.

Rosetta Genomics Ltd. develops and commercializes microRNA-based and other molecular diagnostics. MicroRNAs are a group of genes that are produced using instructions encoded in DNA. The company offers diagnostic tests, including RosettaGX Cancer Origin, a diagnostic for the identification of metastatic cancer; mi-LUNG, a lung cancer classification test for cytology samples; mi-KIDNEY, a kidney tumor classification test for pathology samples; and ... ROSG Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT